Back
Inozyme Pharma Vs. Phathom Pharmaceuticals Industry Stock Comparison
Buy
60
INZY
Inozyme Pharma
Last Price:
4.64
Seasonality Move:
-8.94%
Buy
69
PHAT
Phathom Pharmaceuticals
Last Price:
10.09
Seasonality Move:
-5.21%
Buy
60
Inozyme Pharma (INZY)
is a Buy
Is Inozyme Pharma a Buy, Sell or Hold?
- The current Inozyme Pharma [INZY] share price is $4.64. The Score for INZY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- INZY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $10.10. The Score for PHAT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INZY Stock Price Chart
What is Inozyme Pharma's stock price today?
-
The Inozyme Pharma share price today is $4.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INZY is experiencing buying pressure, which is a positive indicator for future bullish movement.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $10.10
The current trend is moderately bullish and PHAT is experiencing slight selling pressure.
INZY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 41.63 | Sell |
| Chaikin Money Flow: | 343053 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.29 - 5.47) | Sell |
| Bollinger Bands (100): | (4.35 - 6.15) | Sell |
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 53.48 | Buy |
| Chaikin Money Flow: | -138722 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.13 - 10.87) | Buy |
| Bollinger Bands (100): | (7.58 - 10.34) | Buy |
INZY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.62 | Buy |
| 20-day SMA: | 4.63 | Buy |
| 50-day SMA: | 5.6 | Sell |
| 200-day SMA: | 4.66 | Sell |
| 8-day EMA: | 4.64 | Sell |
| 20-day EMA: | 4.83 | Sell |
| 50-day EMA: | 5.19 | Sell |
| 200-day EMA: | 4.9 | Sell |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.83 | Buy |
| 20-day SMA: | 9.65 | Buy |
| 50-day SMA: | 9.8 | Buy |
| 200-day SMA: | 9.97 | Buy |
| 8-day EMA: | 9.95 | Buy |
| 20-day EMA: | 9.82 | Buy |
| 50-day EMA: | 9.61 | Buy |
| 200-day EMA: | 9.72 | Buy |
Inozyme Pharma Earnings Growth & INZY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.04 per share.
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.58 per share, and an increase next year of $1.07 per share.
Inozyme Pharma Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Phathom Pharmaceuticals Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||